Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3022% above fair value
$19.74−0.06 (-0.30%)
Close on Nov 17, 2026Market cap $999.81MP/E –Yield –
Cryoport pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Cryoport's pe ratio was 10.6× on Jul 31, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 10.6× | +2.9 |
| 2025 | Dec 31, 2025 | 7.7× | – |
See a number that looks wrong?